Real-Time PCR, Digital PCR And End-Point PCR Market Overview, Analysis And Demand By 2034

Grab 20% Off With Code ONLINE20 On Global market Reports – Evaluate Global Trends, Market Risks, and Competitive Intelligence

What Is the Estimated Market Size and CAGR of the Real-Time PCR, Digital PCR And End-Point PCR Market for the Period 2025–2029?
The real-time pcr, digital pcr and end-point pcr market size has grown strongly in recent years. It will grow from $38.37 billion in 2024 to $41.55 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to standardization of PCR protocols, role in personalized medicine, contribution to drug discovery and development, adoption in forensic and paternity testing.

The real-time pcr, digital pcr and end-point pcr market size is expected to see strong growth in the next few years. It will grow to " $60.73 billion in 2029 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to expansion of molecular diagnostics, growth in infectious disease testing, increasing demand for genetic testing, market penetration in research and forensics, rapid point-of-care PCR solutions. Major trends in the forecast period include emergence of digital assays, multiplex PCR advancements, shift towards digital PCR technology, automation and high-throughput systems, miniaturization of PCR platforms.

Get your free report sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13296&type=smp

Which Primary Drivers Are Expected to Shape the Future of the Real-Time PCR, Digital PCR And End-Point PCR Market?
The increase in the incidence of infectious diseases is expected to propel the growth of the real-time PCR, digital PCR, and end-point PCR markets going forward. Infectious diseases refer to illnesses caused by the invasion and multiplication of pathogenic microorganisms, including bacteria, viruses, fungi, and parasites. Real-time PCR, digital PCR, and end-point PCR are utilized in infectious diseases to quantify specific pathogens or their genetic material, monitor disease progression, and rapidly diagnose infections such as HIV, hepatitis, respiratory viruses, and tuberculosis. For instance, in July 2023, according to UNAIDS, the Switzerland-based UN program dedicated to addressing the global HIV/AIDS epidemic, the global population living with HIV increased to 39 million in 2022, up 3.17% from 37.7 million in 2020. Moreover, there were approximately 1.3 million new HIV infections reported in 2022. Furthermore, in March 2023, according to the Centers for Disease Control and Prevention, a US-based national public health organization, in the United States, 8,300 cases of tuberculosis (TB) were reported in 2022, a rise from 7,874 cases in 2021. Therefore, the increase in the incidence of infectious diseases will drive the growth of the cephalosporin market.

Which Segments Are Likely to Shape the Future Outlook of the Real-Time PCR, Digital PCR And End-Point PCR Market?
The real-time pcr, digital pcr and end-point pcrmarket covered in this report is segmented –

1) By Product: Instruments; Consumables And Reagents; Software And Services
2) By Technology: Quantitative; End-Point Polymerase Chain Reaction (PCR); Digital
3) By Applications: Clinical; Research; Forensic; Other Applications
4) By End User: Hospital; Diagnostic Labs; Pharma; Biotech; Contract Research Organizations

Subsegments:
1) By Instruments: Real-Time PCR Systems; Digital PCR Systems; End-Point PCR Systems
2) By Consumables And Reagents: PCR Plates And Tubes; Primers And Probes; PCR Master Mix; DNA Polymerases And Nucleotides
3) By Software And Services: Analysis Software; Data Management Software; Calibration And Maintenance Services; Training And Support Services


Which Future-Ready Trends Are Expected to Influence the Real-Time PCR, Digital PCR And End-Point PCR Market?
Major companies operating in the real-time PCR, digital PCR, and end-point PCR markets are developing innovative products using advanced technologies such as digital polymerase chain reaction (dPCR) technology to better understand the nature of a patient’s cancer, genetic disease, or infection. Digital polymerase chain reaction (dPCR) technology is a biotechnological refinement of conventional polymerase chain reaction (PCR) methods that can directly quantify and clonally amplify nucleic acid strands, including DNA, cDNA, or RNA. For instance, in August 2022, Roche Diagnostics, a US-based manufacturer of medicines and medical devices, launched the next-generation digital PCR Digital LightCycler System for early detection and treatment of various chronic and genetic disorders. The system is designed to automate workflow and manage data, eliminating the need for external calculations, software, and processors. A combination of three nano well plate configurations, six advanced optical channels, and 5x concentrated DNA and RNA master mixes provides high sensitivity and precision. The Digital LightCycler System is a valuable addition to Roche's portfolio of diagnostic platforms, providing advanced technology, clinical applications, customization and flexibility, and workflow automation.

Which Firms Represent the Competitive Benchmark Within the Real-Time PCR, Digital PCR And End-Point PCR Market?
Major companies operating in the real-time PCR, digital PCR and end-point PCR market report are F. Hoffmann La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Co., GE HealthCare Technologies Inc., Agilent Technologies Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc., Cole-Parmer Instrument Company LLC, Bioneer Corporation, Enzo Life Sciences Inc., Analytik Jena AG, Fluidigm Corporation, Elitech Group SAS, Microsynth AG, Stilla Technologies SAS, HTG Molecular Diagnostics Inc., AITbiotech Pte Ltd., Bio Molecular Systems, JN Medsys Pte Ltd., Biomeme Inc.

Get the detailed real-time pcr, digital pcr and end-point pcr market report today
https://www.thebusinessresearchcompany.com/report/real-time-pcr-digital-pcr-and-end-point-pcr-global-market-report

Which Regions Are Driving the Highest Demand in the Real-Time PCR, Digital PCR And End-Point PCR Market?
North America was the largest region in the real-time PCR, digital PCR, and end-point PCR market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time PCR, digital PCR and end-point PCR market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company